Show simple item record

dc.contributor.authorConseil exécutif, 115
dc.coverage.spatialGenèveen
dc.date.accessioned2012-02-29T09:01:27Z
dc.date.available2012-02-29T09:01:27Z
dc.date.issued2005
dc.identifier.govdocEB115/27
dc.identifier.urihttps://apps.who.int/iris/handle/10665/20736
dc.descriptionConseil exécutif, cent quinzième session, point 9.1 de l’ordre du jour provisoire, 9 p.en
dc.language.isofren
dc.publisherOrganisation mondiale de la Santéen
dc.subjectProduits pharmaceutiques et médicamentsen
dc.subjectVaccinsen
dc.subjectSécurité sanitaire des alimentsen
dc.subjectTabagismeen
dc.subject.meshBiological Productsen
dc.subject.meshReference Standardsen
dc.subject.meshVaccinesen
dc.subject.meshSmallpox Vaccineen
dc.subject.meshPoliovirus Vaccinesen
dc.subject.meshInfluenza Vaccinesen
dc.subject.meshFood Additivesen
dc.subject.meshFood Contaminationen
dc.subject.meshVeterinary Drugsen
dc.subject.meshTobacco Industryen
dc.titleComités d’experts et groupes d’étude : rapport du Secrétariaten
dc.typeGoverning body documentsen
dc.subject.meshqualifiernormesen
dc.subject.meshqualifierressources et distributionen
dc.subject.meshqualifiertoxicitéen
dc.subject.meshqualifierlégislation et jurisprudenceen
who.relation.languageVersion10665/68817en
who.relation.languageVersion10665/22273en
who.relation.languageVersion10665/25347en
who.relation.languageVersion10665/22351en
who.relation.languageVersion10665/21641en
who.relation.languageVersion10665/20221en


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

  • EB115
    17-25 January 2005

Show simple item record